MD2 Biosciences Inc
MD2 Biosciences is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics in oncology and pulmonary fibrosis. They leverage artificial intelligence (AI) in drug discovery and optimization, utilizing a novel platform to identify small-molecule hits for flat proteins. Their methodology predicts potential hotspots and assigns a protein-ligand specificity index, aiding in lead generation and optimization. The company aims to develop best-in-class or first-in-class programs to address high unmet needs in oncology, including colorectal cancer, gastrointestinal stromal tumors, and brain cancer, as well as pulmonary fibrosis.
MD2 Biosciences Inc
MD2 Biosciences is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics in oncology and pulmonary fibrosis. They leverage artificial intelligence (AI) in drug discovery and optimization, utilizing a novel platform to identify small-molecule hits for flat proteins. Their methodology predicts potential hotspots and assigns a protein-ligand specificity index, aiding in lead generation and optimization. The company aims to develop best-in-class or first-in-class programs to address high unmet needs in oncology, including colorectal cancer, gastrointestinal stromal tumors, and brain cancer, as well as pulmonary fibrosis.